MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/fpc.0000000000000468

Медицинская библиотека · Pharmacogenetics and genomics · 2022

Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis.

Dai Qinghong, Xia Xuyang, He Chenjia, Huang Yupeng, Chen Yidan, Wu Yang, Chen Yuehong, Hou Qianqian, Shu Yang, Zhang Wei, Xu Heng, Yin Geng, Xie Qibing

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Gut dysbiosis contributes to multiple autoimmune diseases, including ankylosing spondylitis, which is commonly treated with tumor necrosis factor (TNF)-α inhibitors (TNFis). Because host TNF-α levels are considered to interact with gut microbiota, we aimed to systematically investigate the microbiota profile of ankylosing spondylitis patients with anti-TNF-α-based treatment and identify potential key bacteria.

METHODS

Fecal samples were collected from 11 healthy controls and 24 ankylosing spondylitis patients before/after anti-TNF-α treatment, the microbiota profiles of which were evaluated by 16S ribosomal DNA amplicon sequencing and subsequent bioinformatic analysis.

RESULTS

Significantly different microbial compositions were observed in samples from ankylosing spondylitis patients compared with healthy controls, characterized by a lower abundance of short-chain fatty acid (SCFA)-producing bacteria. All patients exhibited a positive response after anti-TNF-α treatment, accompanied by a trend of restoration in the microbiota compositions and functional profile of ankylosing spondylitis patients to healthy controls. In particular, the abundance of SCFA-producing bacteria (e.g. Megamonsa and Lachnoclostridium ) was not only significantly lower in ankylosing spondylitis patients than in healthy controls and restored after anti-TNF-α treatment but also negatively correlated with disease severity (e.g. cor  = -0.52, P  = 8 × 10 -5 for Megamonsa ). In contrast, Bacilli and Haemophilus may contribute to ankylosing spondylitis onset and severity.

CONCLUSIONS

Microbiota dysbiosis in ankylosing spondylitis patients can be restored after anti-TNF-α treatment, possibly by impacting SCFA-producing bacteria.

Для цитирования: Dai Qinghong, Xia Xuyang, He Chenjia, Huang Yupeng, Chen Yidan, Wu Yang, Chen Yuehong, Hou Qianqian, Shu Yang, Zhang Wei, Xu Heng, Yin Geng, Xie Qibing. Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis.. Pharmacogenetics and genomics. 2022. DOI: 10.1097/fpc.0000000000000468.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.